Sino Biopharm block fetches $406m, stock plunges
siro46 - stock.adobe.com
Sino Biopharmaceutical’s chief executive Tse Ping has sold a portion of his stake in the company for the second time this year, pocketing HK$3.15bn ($406.4m) but causing the stock price to tumble in the secondary market.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: